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Effectiveness of pelvic floor muscle training on symptoms and uroflowmetry
parameters in female patients with overactive bladder
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Background/aim: To evaluate the effects of pelvic floor muscle training (PFMT) on symptoms of overactive bladder (OAB) as well as
uroflowmetry parameters and functional bladder capacity.
Materials and methods: Fifty-nine female patients with OAB symptoms were included. Patients were assessed by SEAPI-QMM,
uroflowmetry, and abdominal ultrasound. A specially designed PFMT program using a Pilates ball was generated for patients. The
training period was 1-h sessions twice a week for 6 weeks and aerobic home exercises to be performed at home 4 or 5 times every other
day. Following training, subjects were reevaluated for body mass index, SEAPI questionnaire, and uroflowmetry.
Results: Initial mean SEAPI score, mean maximum and average flow rates, and mean voided volume were 9.8 ± 7.2, 29.8 ± 16.4 mL/s,
16.3 ± 8.7 mL/s, and 211.6 ± 173.5 mL, respectively. After completion of the training program, SEAPI scores improved significantly to
3.4 ± 6.4 (P < 0.05). Maximum and average flow rate results did not show significant changes, whereas voided volume seemed to have
improved in conjunction with patients’ symptom scores (Pearson correlation coefficient: 0.86).
Conclusion: According to our results, we think that proper PFMT results in increase of functional bladder capacity as well as
improvement in OAB symptoms and can be recommended as first-line therapy or in conjunction with medical therapy in severe cases.
Key words: Overactive bladder, pelvic floor muscle training, incontinence, uroflowmetry

1. Introduction
Overactive bladder (OAB) symptoms are devastating and
have been reported to affect at least 11.8% of both the male
and female populations in the most recent international
population-based survey (1). Lifestyle changes have been
suggested to help alleviate the OAB symptoms in women.
Among the lifestyle changes, dietary modifications to
avoid irritants, voiding training, and liquid intake control
have previously been proven to improve patients’ quality
of life (2). Pelvic floor muscle training (PFMT) has been
one of the most effective treatment modalities in bladder
symptoms (3).
Kegel exercises, the pioneer in PFMT, were popularized
by Arnold Kegel to be applied by women in the postpartum
period to avoid stress urinary incontinence (SUI) (4). It has
been widely accepted and used among both the urological
and gynecological communities. Its use as a treatment for
SUI has been logically well established since pelvic muscle
and supportive tissue strength and elasticity are the key
elements for the bladder outlet control in SUI; however,
* Correspondence: drmuratakand@yahoo.com

the mechanism for OAB symptomatology has not been
clarified (5).
Most patients with OAB symptoms usually have
increased urinary flow rates with a voided volume
below normal values. This study was planned to evaluate
the effects of PFMT on the symptoms of OAB as well
as uroflowmetric parameters and functional bladder
capacity. We aimed to investigate the initial uroflowmetry
parameters of the patients with OAB and the possible
differences after the training program, if any.
2. Materials and methods
Fifty-nine female patients presenting with OAB symptoms
to the Selçuk University School of Medicine’s Department
of Urology were included in the study. All participants were
naive to any form of treatment for OAB symptoms and did
not have a history of delivery and/or medical abortion in
the last 12 months. All patients were informed about the
treatment options for OAB and recruitment was totally
voluntary. All patients provided their written informed
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consent for participation. Those patients who had had
a pelvic surgery, lumbosacral disc disease, or known
cardiac or pulmonary disabilities that may be affected by
exercise; those actively receiving medical therapy for OAB
symptoms; and those with known neurological diseases
that affect urinary system (such as stroke, Parkinson
disease, multiple sclerosis, etc.) were excluded from the
study. The study, which followed the principles of the
Helsinki Declaration, was approved by the local ethics
committee (approval number B.30.2.SEL.0.28.00/130).
The OAB symptoms were assessed by the SEAPIQMM questionnaire. The SEAPI-QMM Incontinence
Classification System was developed in the early 1990s
as a system that could quantify urinary incontinence and
its impact without special equipment or time-consuming
procedures (6). SEAPI-QMM is an acronym for stressrelated leak (S), emptying ability (E), anatomy (female) (A),
protection (P), inhibition (I), quality of life (Q), mobility
(M), and mental status (M). Quality of life (Q) related
to incontinence is measured with an index consisting of
a 15-item questionnaire that examines a broad variety of
aspects of a patient’s life (domains). Patients filled in the
validated Turkish version of SEAPI-QMM questionnaire
(7). All patients had weight and height measurements and
body mass indices (BMIs) were calculated. Childbearing
histories and medical and pharmaceutical aspects were
noted. A uroflowmetry test was initially performed for all
patients. Maximum flow rate, mean flow rate, and voided
bladder capacity were the end-points for the uroflowmetry
test.
A specially designed PFMT program was generated for
this patient group using a Pilates ball by the Department of
Physical Education and Training. The exercise period was
1-h sessions 3 times a week for 6 weeks in a public gym
supervised by a certified Pilates coach and aerobic home
exercises to be performed personally at home for 4 or 5
times every other day. For the first 3 weeks, each session
consisted of 10 min of warming up, 40 min of a Pilates mat

exercise program of 8 × 2 sets, and 10 min to cool down.
For the following 3 weeks, there was 45 min of the Pilates
mat exercise program of 8 × 3 sets with the warming up
and cooling down times remaining the same. The coach
showed each exercise and then provided verbal cues and
physical assistance for the accuracy of subject movements.
The Pilates exercise program is accepted universally and
is seen in Table 1 (8,9). Following the exercise program
for 6 weeks, the subjects were reevaluated for BMI,
SEAPI incontinence questionnaire, and uroflowmetry
parameters.
All tests were analyzed using the t-test and P < 0.05 was
accepted as statistically significant. A regression analysis
was performed for the causal relationship.
3. Results
The mean age of the study group was 38.4 ± 9.8 years
(range: 22–54 years). Thirty-eight patients had 2 children,
15 patients had 3 children, and 5 patients had 1 child,
while 1 patient did not have a childbearing history. The
initial mean SEAPI score of the group was 9.8 ± 7.2.
Pure urge incontinence was reported in 38 of the total 59
patients. There were no drop outs during the program and
all participants completed the training period.
The average maximum flow rate was 29.8 ± 16.4 mL/s,
while initial average flow rate and mean voided volume
were 16.3 ± 8.7 mL/s and 211.6 ± 173.5 mL, respectively.
The BMIs were high in the study group with a mean BMI
of 26.6 ± 5.1 kg/m2.
After the completion of the training program, SEAPI
scores improved significantly to 3.4 ± 6.4 (P < 0.05).
There seemed to be a drop in the flow rate parameters
(both maximum and average flow rates), but this did not
reach statistical significance. Voided volume was the only
parameter that seemed to have improved after the training
program in conjunction with the improvement in patients’
symptom scores (Pearson correlation coefficient: 0.86). All
results are summarized in Table 2.

Table 1. The training program.
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Weeks 1–3

Weeks 4–6

Monday

10 min warm up
40 min Pilates mat exercises (8 × 2)
10 min cool down

10 min warm up
45 min Pilates mat & ball exercises (8 × 3)
10 min cool down

Wednesday

10 min warm up
40 min Pilates mat exercises (8 × 2)
10 min cool down

10 min warm up
45 min Pilates mat & ball exercises (8 × 3)
10 min cool down

Friday

10 min warm up
40 min Pilates mat & ball exercises (8 × 2)
10 min cool down

10 min warm up
45 min Pilates mat & ball exercises (8 × 3)
10 min cool dawn
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Table 2. The mean initial and postexercise uroflowmetric parameters, voided urine volumes,
and SEAPI scores of the group.
Initial

After exercise

P-value

Qmax (mL/s)

29.8

26.2

>0.05

Qave (mL/s)

16.3

12.5

>0.05

Vvoided (mL)

211.6

290.0

<0.05

SEAPI Score

9.8

3.4

<0.05

Qmax: Maximum flow rate, Qave: Average flow rate, Vvoided: Voided volume.

4. Discussion
Incontinence rates have been proven to be one of the
most prevalent and bothersome health issues in both
women and men. The urinary symptoms associated
with OAB have been reported to be as 11.8% among the
general population in a multiinstitutional survey and the
prevalence increases as age increases (1). In relation to this
high incidence, many therapeutic approaches have been
suggested. Medical management offers patients comfort
but may require long treatment periods, side effects such
as constipation that can be bothersome to most females,
and of course a high medical bill. Conservative approaches
are recommended in patients with OAB symptoms solely
or in conjunction with medical therapies in order to
increase effectiveness, decrease side effect profile and
costs, and give patients a more permanent therapy that
they personally can control and apply (10,11).
The most effective conservative approach has been
reported to be PFMT. The pelvic floor muscles (PFMs)
comprise the pelvic diaphragm separate from the
urogenital diaphragm and urethral sphincter muscles,
and they consist of several muscles with different fiber
directions (12,13). The PFMs form a U-shaped sling
around the urethra, vagina, and anus, and contraction of
the muscles has a direct influence on the urethra because
they compress the urethra, thereby increasing the urethral
pressure (12–14). Disorders of the PFMs may lead to
bladder control problems, retention, prolapse, or sexual
dysfunction.
Although the effect of PFMT on OAB pathogenesis
has not been clearly explained, there are some data from
anatomical studies about PFMs and bladder interaction.
The PFMs and bladder transmit afferent information to
the lumbosacral cord and the periaqueductal gray matter
(PAG) (15). The pontine micturition center (PMC) receives
excitatory information from the PAG. In the PMC, there
are two regions, namely the medial (M) and lateral (L)
region, which have reciprocal inhibitory effects on each
other. The M-region is the center of synergetic micturition
with projections to the bladder and the urethral sphincter.

The L-region has direct projections on the nucleus of Onuf
and in this way initiates contraction of the PFMs and
striated sphincter of the urethra and anus (16).
In a normal situation, the PFMs and bladder are
coordinated at the level of the PMC under control of the
PAG. The effect of a contraction of the PFMs on the bladder
is the inhibition of the detrusor contraction (17). This
reflex mechanism may be of sacral origin, but the role of the
PMC in this mechanism has been described as inhibition
of the L-region on the M-region (18). A similar effect
can be observed when PFMT is used in the conservative
treatment of OAB. PFMT leads to hypertrophy of local
skeletal muscle fibers, enhanced cortical awareness of
muscle groups, strengthening of connective tissue in the
muscles, and more effective recruitment of active motor
neurons (13).
The aim of this study was to establish the efficacy of
PFMT on OAB symptomatology and which uroflowmetry
parameters correlated with this change in symptom
improvement. Our results showed an improvement in
the symptom scores of the patients, but no change in the
maximum or the mean flow rates. However, the mean
voided volume showed an increase that correlated with
the SEAPI scores.
In order to predict whether PFMT may be effective
in treating OAB symptoms, it is necessary to know the
status of the PFMs. On physical examination, three types
of pelvic floor dysfunction can be seen: no voluntary
control, voluntary control but impaired strength and/or
relaxation, and voluntary control with normal strength
and/or relaxation. PFMT is the treatment of choice when
there is voluntary control but strength and/or relaxation is
impaired. The most important feature of PFMT is training
the coordination between bladder and PFMs (19).
The effect of PFMT on urgency may be explained by the
anatomical structures related to voiding. Detrusor muscles
are the main component of compliance and voiding
physiology and are under the control of both the somatic
and sympathetic nervous system. The main pathology
resulting in OAB symptoms is yet to be identified. Since
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people may experience OAB symptoms without abnormal
detrusor contractions and even with normal urodynamic
findings, we think that there may be different types of
OAB involving the bladder itself or the nervous system
innervations. Pudendal nerve stimulation has been
proposed as one of the most effective models for alleviating
OAB symptoms in electric stimulation therapies for urge
incontinence (20,21). It is highly possible that proper PFM
stimulation through exercise may have a similar effect on
the pudendal nerve and thus result in the improvement of
the OAB symptoms (22–24).
Numerous recently done studies have shown the
efficacy of PFMT on urinary incontinence and OAB
symptoms. Dugan et al. showed that the patients older
than 65 years and participating in PFMT classes twice a
week for 6 weeks experienced significant improvement in
all self-administered questionnaires when compared to
the control group having only one educational session and
didactic information via a booklet (25). Fan et al. evaluated
the effects of PFMT on the urinary symptoms and quality
of life. Participants participating in 3 to 9 months of
PFMT observed improvement both in their urinary
symptom scores and in their quality of life regardless of
their diagnosis of SUI, OAB symptoms, or mixed urinary
incontinence (26).
Another study evaluated the effects of PFMT on
lower urinary tract symptoms (LUTS) and quality of life
in women with multiple sclerosis. The authors observed

statistically significant improvement in the scores of all
questionnaires assessing LUTS and quality of life after
performing PFMT for 12 weeks (27). A different study
involving 143 male patients receiving alpha-blocker
therapy compared the effectiveness of behavioral treatment
with that of antimuscarinic therapy. It was observed that
behavioral treatment consisting of PFMT, urge suppression
techniques, and delayed voiding was at least as effective as
antimuscarinic therapy for OAB in men without bladder
outlet obstruction (28).
It is obvious that PFMT is effective in OAB symptoms
as well as SUI. The actual question is for how long PFMT
should be done. There are miscellaneous treatment
protocols in the literature and no consensus exists for
the ideal duration. In most of the studies, however, it is
advised to perform PFMT at least for 6–8 weeks. It makes
sense that the longer the duration of PFMT is, the better
results the patients get.
Our study is the first reported on the effect of PFMT
on correlation of uroflowmetry parameters and OAB
symptoms. Uroflowmetry, as an easy, noninvasive, and
cheap test, can be done in the first evaluation of patients
with OAB symptoms as well as in their follow-up for
the effects of the treatment. We think that proper PFMT
results in increase of functional bladder capacity as well as
improvement in OAB symptoms and can be recommended
as a first line of therapy or in conjunction with medical
therapy in severe cases.
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